Skip to content

Mortality falls in HIV/HCV coinfected Spaniards after the introduction of effective HIV treatment

Non-Hodgkin's lymphoma risk increased with prolonged high HIV viral load

ICAAC: HCV only factor associated with liver problems in patients starting HIV treatment in 2004

HAART reduces liver damage in HIV / hepatitis C co-infected patients

HIV-positive injecting drug users who are infected with HTLV-II less are less likely to progress to AIDS

Higher doses of pegylated interferon or ribavirin improve hepatitis C treatment response rates

Non-invasive markers of liver damage effective in HIV / hepatitis C co-infected patients

Hospitalisations and deaths down in US, slight increase in number of admissions due to liver problems

Liver disease causing larger proportion of deaths since introduction of HAART